Fujifilm plots $928M infusion at Danish biologics plant to double production capacity

Fujifilm's infusion into its Denmark site comes weeks after the Japanese drugmaker agreed to set aside manufacturing space at the site for the Bill Gates-funded COVID-19 Therapeutics Accelerator. In late April, Fujifilm agreed to dedicate room at the Hillerød, Denmark, facility and 'work with a selected pharmaceutical partner in supporting the swift manufacture and dedicated supply for patients with COVID-19 in lower-income countries,' the drugmaker said in a release. The deal set aside an unspecified production volume for 2021 with options for the following years.